Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP

GSK bone cancer treatment gets USFDA Breakthrough Therapy Designation

Written By Ruchika Sharma7 Jan 2025 3:00 PM IST

London: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation for GSK5764227...

Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC Irregularities

Zydus Lifesciences arm application for Menkes disease treatment gets USFDA priority review

Written By Ruchika Sharma7 Jan 2025 2:00 PM IST

Solana Beach: Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd., and Fortress Biotech,...

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS

Written By Ruchika Sharma7 Jan 2025 1:15 PM IST

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

USFDA issues EIR for Caplin Steriles Gummidipoondi facility

Written By Ruchika Sharma7 Jan 2025 11:30 AM IST

Chennai: Caplin Point Laboratories Ltd. has announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug...

CSIR Indigenously developed "Paracetamol" announced by Dr Jitendra Singh

Written By Ruchika Sharma6 Jan 2025 4:34 PM IST

New Delhi: Union Minister Dr. Jitendra Singh, Minister of State (Independent Charge) for Science and Technology, Earth Sciences (Independent Charge),...

Bayer new drug application for gadoquatrane accepted for review in China

Federal Court brings end to Roundup litigation in Australia: Bayer

Written By Ruchika Sharma6 Jan 2025 10:00 AM IST

Leverkusen: Bayer has announced that the Federal Court of Australia brought an end to the last Roundup case in Australia, closing all pending...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Atavistik Bio, Pfizer collaborate to accelerate discovery of novel precision Allosteric Therapeutics

Written By Ruchika Sharma5 Jan 2025 10:00 AM IST

Cambridge: Atavistik Bio, a biotechnology company has announced that it has entered into a research collaboration with Pfizer to accelerate the...

Govt Moves to Fix Import Price Floor for Penicillin APIs to Protect PLI Investments

Alcium-D3 tablets worth Rs 1.5 lakhs seized in Uppal

Written By Ruchika Sharma4 Jan 2025 5:00 PM IST

Telangana: Drugs Control Administration, Telangana has seized Alcium-D3 Tablets (Calcium with Vitamin D3 Tablets) worth Rs. 1.5 lakhs in Kothapet...

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

Codeine-based cough syrup worth Rs 2 crore seized in Assam

Written By Ruchika Sharma4 Jan 2025 3:06 PM IST

Cachar: More than 11000 bottles of Codeine-based cough syrup valued at Rs two crore have been seized by Assam Police from a vehicle near...

GSK Nucala approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps

Written By Ruchika Sharma4 Jan 2025 1:00 PM IST

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a monoclonal antibody...

Wockhardt to exit US generic pharmaceutical segment

Miqnaf: CDSCO nod to Wockhardt 3-day treatment for Community-Acquired Bacterial Pneumonia

Written By Ruchika Sharma3 Jan 2025 4:40 PM IST

Mumbai: The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf(nafithromycin) as a new treatment for...

Telangana DCA Introduces SMS Alerts For Substandard Medicines

Telangana DCA seizes certain medicines for misleading advertisements

Written By Ruchika Sharma3 Jan 2025 4:15 PM IST

Telangana: Drugs Control Administration, Telangana officials, seized certain medicines circulating in the market with misleading claims on their...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok